HOME › Research Insight › Epigenetics – A Promising Tool for Personalized Medicine and Diagnostics
Epigenetics – A Promising Tool for Personalized Medicine and Diagnostics
Epigenetics Technology Market also covers the market by research and diagnostics sector in gene regulation studies, biomarker detection and drug discovery. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.
In the post genomic era, Epigenetics has been gaining importance as a promising scientific approach for understanding the influence of the epigenetic mechanisms in cancer and various other diseases. Rapid advancements have been occurring specifically in the field of cancer therapeutics.
Industry is witnessing a wider acceptance as more number of academic research universities, biotech and pharma companies are willing to adopt Epigenetics based approach in diagnostics and therapeutics.
The pharmaceutical industry has experienced a considerable growth based on sales revenues of the four epigenetic drugs, for example around $1 Billion in the year 2011 and is expected to have an increased growth rate in the coming years. Therapeutic applications in non-oncology indications such as inflammatory diseases, autoimmune diseases, neurodegenerative disorders and personalized medicine are some high growth and emerging areas that are expected to drive the global market of Epigenetics in coming years.
For the pharma industry, this field of research provides a unique opportunity within drug discovery and proves to be an emerging field with the potential to offer novel drugs implicated in many diseases primarily from a cancer perspective in order to develop the best possible therapeutic option. In addition, Epigenetics platform has also the potential to enable personalized medicine by creating better therapeutic options for the right patients in quick time and at low cost than traditional methods.
A wide range of molecular biologic techniques are used in epigenetic diagnostic applications. A number of small companies are developing highly sensitive cancer diagnostics based on differences in DNA methylation between healthy and diseased tissues.
The market for Epigenetics screening tools such as enzymes, ChIP kits, assays for analyzing various epigenetic mechanisms are also increasing at a higher rate due to increased utilization in the research field. Owing to this, there has been a significant growth in biotechnology industry based on the revenues from epigenetic tools.
In 2012, North America was the largest market accounting for 40 percent of the overall Epigenetics market and followed by Europe which accounted for 36%. Though North America has a large market value, Asia-Pacific will majorly drive the growth of Epigenetics market in future owing to the favorable regulatory landscape and increased population with cancer, diabetes, cardiovascular diseases, etc. Similarly, based on the application segments the major portion of the market (51%) in 2012 is occupied by oncology conditions due to healthy sales of the four Epigenetic drugs available in the market for treatment of Cutaneous T-Cell Lymphoma (CTCL) and Myelodysplastic syndrome (MDS).
MarketsandMarkets provided this basic information from its latest research report. The "Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)" report is now available for sale.
Related Reports @
Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252